BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11404017)

  • 1. Isolation and characterization of the murine transforming growth factor-beta2 promoter.
    Wilder PJ; Desler MM; Nowling TK; Rizzino A
    Gene; 2001 May; 270(1-2):201-9. PubMed ID: 11404017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of the chicken transforming growth factor-beta 3 promoter.
    Jakowlew SB; Lechleider R; Geiser AG; Kim SJ; Santa-Coloma TA; Cubert J; Sporn MB; Roberts AB
    Mol Endocrinol; 1992 Aug; 6(8):1285-98. PubMed ID: 1406706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the TGF-beta 2 gene in choriocarcinoma cells and breast carcinoma cells: differential utilization of Cis-regulatory elements.
    Kingsley-Kallesen M; Johnson L; Scholtz B; Kelly D; Rizzino A
    In Vitro Cell Dev Biol Anim; 1997 Apr; 33(4):294-301. PubMed ID: 9156346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the transforming growth factor-beta2 promoter by cAMP-responsive element-binding protein (CREB) and activating transcription factor-1 (ATF-1) is modulated by protein kinases and the coactivators p300 and CREB-binding protein.
    Kingsley-Kallesen ML; Kelly D; Rizzino A
    J Biol Chem; 1999 Nov; 274(48):34020-8. PubMed ID: 10567368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of human and chicken transforming growth factor-beta 2 and -beta 3 promoters.
    Burt DW; Paton IR; Dey BR
    J Mol Endocrinol; 1991 Dec; 7(3):175-83. PubMed ID: 1840616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-beta 2 promoter.
    O'Reilly MA; Geiser AG; Kim SJ; Bruggeman LA; Luu AX; Roberts AB; Sporn MB
    J Biol Chem; 1992 Oct; 267(28):19938-43. PubMed ID: 1400310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the infection-responsive bovine lactoferrin promoter.
    Zheng J; Ather JL; Sonstegard TS; Kerr DE
    Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
    Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
    Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fli-1b is generated by usage of differential splicing and alternative promoter.
    Dhulipala PD; Lee L; Rao VN; Reddy ES
    Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the murine Pit1 phosphate transporter/retrovirus receptor gene and functional characterization of its promoter region.
    Palmer G; Manen D; Bonjour J; Caverzasio J
    Gene; 2000 Feb; 244(1-2):35-45. PubMed ID: 10689185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional characterization of the transforming growth factor beta 3 promoter. A cAMP-responsive element regulates basal and induced transcription.
    Lafyatis R; Lechleider R; Kim SJ; Jakowlew S; Roberts AB; Sporn MB
    J Biol Chem; 1990 Nov; 265(31):19128-36. PubMed ID: 2146270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG).
    Kakar SS
    Gene; 1999 Nov; 240(2):317-24. PubMed ID: 10580151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2.
    Kim SJ; Wagner S; Liu F; O'Reilly MA; Robbins PD; Green MR
    Nature; 1992 Jul; 358(6384):331-4. PubMed ID: 1641004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic organization and promoter characterization of the murine dopamine receptor regulating factor (DRRF) gene.
    Lee SH; Kim YM; Yajima S; Ha JM; Ha BJ; Kim OS; Ohsawa K; Mouradian MM
    Gene; 2003 Jan; 304():193-9. PubMed ID: 12568728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the promoters for the human bone morphogenetic protein 2 and 4 genes.
    Helvering LM; Sharp RL; Ou X; Geiser AG
    Gene; 2000 Oct; 256(1-2):123-38. PubMed ID: 11054542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter.
    Liu Y; Michalopoulos GK; Zarnegar R
    J Biol Chem; 1994 Feb; 269(6):4152-60. PubMed ID: 8307976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple protein-binding domains and functional cis-elements in the 5'-flanking region of the human pyruvate dehydrogenase alpha-subunit gene.
    Chang M; Naik S; Johanning GL; Ho L; Patel MS
    Biochemistry; 1993 Apr; 32(16):4263-9. PubMed ID: 8476854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, characterization, and differential expression of the murine Sox-2 promoter.
    Wiebe MS; Wilder PJ; Kelly D; Rizzino A
    Gene; 2000 Apr; 246(1-2):383-93. PubMed ID: 10767561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse interferon-inducible RNA-dependent protein kinase Pkr gene: cloning and sequence of the 5'-flanking region and functional identification of the minimal inducible promoter.
    Tanaka H; Samuel CE
    Gene; 2000 Apr; 246(1-2):373-82. PubMed ID: 10767560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and structure of the human transforming growth factor-beta 2 gene promoter.
    Noma T; Glick AB; Geiser AG; O'Reilly MA; Miller J; Roberts AB; Sporn MB
    Growth Factors; 1991; 4(4):247-55. PubMed ID: 1764261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.